Prospective study on concentration-efficacy and concentration-toxicity: Correlations with lamotrigine serum levels

Epileptic Disorders

Volumn 4, Issue 1, 2002, Pages 49-55

  Fröscher, Walter ^a   Keller, Ferdinand ^a   Vogt, Heinrich ^a   Krämer, Günter ^a  

^a Weissenau ^*  (Germany)

Author keywords

Adverse effects; Epilepsy; Lamotrigine; Therapeutic drug monitoring

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; LAMOTRIGINE; MESUXIMIDE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID; VIGABATRIN;

ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDUCED DISEASE; EPILEPSY; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; FOCAL EPILEPSY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSOMNIA; MALE; MYOCLONUS SEIZURE; PRIORITY JOURNAL; TONIC CLONIC SEIZURE; TREATMENT OUTCOME; TREMOR; VERTIGO;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRIAZINES;

EID: 0036225896     PISSN: 12949361     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Serum-level monitoring in assessing lamotrigine efficacy and toxicity
2. Relationship between lamotrigine's serum concentration and seizure outcome in patients with poorly controlled partial seizure disorders
3. A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures
4. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures
5. Lamotrigine and therapeutic drug monitoring: Retrospective survey following the introduction of a routine service
6. Combination vigabatrin and lamotrigine therapy for intractable epilepsy
7. Vigabatrin and lamotrigine in refractory epilepsy
8. Gamma-Vinyl-GABA (Vigabatrin) and lamotrigine: Synergism in refractory epilepsy?
9. The Swiss Lamotrigine study: Results of an open, multicenter, add-on treatment with lamotrigine in drug resistant epileptic patients
10. Lamotrigine serum levels are useful in the clinical setting
11. Lamotrigine serum level monitoring in clinical practice
12. The influence of dosage, age, and comedication on steady state plasma lamotrigine concentrations in epileptic children: A prospective study with preliminary assessment of correlations with clinical response
13. Double-blind, placebo-controlled, crossover study of lamotrigine in treatmentresistant generalized epilepsy
14. Controlled trial of lamotrigine (Lamictal) for treatment-resistant partial seizures
15. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepy: A randomized, double-blind, crossover study
16. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures
17. Are lamotrigine concentrations clinically used? A prospective study
18. Lamotrigine for generalized seizures associated with the Lennox-Gastaud syndrome
19. Lamotrigine in refractory epilepsy: A long-term open study
20. The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy
21. The role of blood-level monitoring in assessing lamotrigine toxicity
22. Anläßlich der einführung eines neuen antiepileptikums: Lamotrigin
23. Therapeutic range of lamotrigine (LTG) serum concentrations: Do LTG serum concentrations correlate with antiepileptic effect and side effects?
24. Korrelieren lamotrigin-serumkonzentrationen mit dem antiepileptischen effekt und mit nebenwirkungen?
25. Lamotrigine-induced carbamazepine toxicity: An interaction with carbamazepine-10, 11-epoxide
26. Lamotrigine add-on treatment in mentally retarded patients: Pharmacokinetic or pharmacodynamic interactions?
27. Is there a relationship between the occurrence of adverse effects from lamotrigine and its serum concentration
28. Survey of treatment with lamotrigine and vigabatrin in children with severe epilepsy
29. Alkylamine/phosphoric acid as a universal buffer system for basic and acidic mobile phases in HPLC
30. Extrelut® bei der HPLC-analyse von antiepileptika
31. Simultaneous determinations of eleven antiepileptic compounds in serum by high-performance liquid chromatography
32. The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy
33. Lamotrigine
34. Lamotrigine therapy for partial seizures. A multicenter, placebo-controlled, double-blind, cross-over trial
35. Lamotrigine (Lamictal) in resistant childhood epilepsy
36. Lamotrigin in der Behandlung von kindlichen Epilepsien
37. Lamotrigine. A review of its use in childhood epilepsy
38. Lamotrigine serum concentration-to-dose ratio: Influence of age and concomitant antiepileptic drugs and dosage implications
39. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy
40. Lamictal (lamotrigine) monotherapy for typical absence seizures in children
41. Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: Results of a retrospective study
42. High-performance liquid chromatography quantitation of plasma lamotrigine concentrations: Application measuring trough concentrations in patients with epilepsy
43. The relationship between lamotrigine concentrations as adjunctive therapy and the reduction in seizure frequency and toxicity
44. Lamotrigine plasma concentrations in children and adults: Influence of age and associated therapy
45. Routine therapeutic monitoring of lamotrigine in epileptic patients using a simple and rapid high performance liquid chromatographic technique
46. Lamotrigine
47. Safety review of adult clinical trial experience with lamotrigine
48. Is there a role for therapeutic drug monitoring of new anticonvulsants?
49. The efficacy of lamotrigine
50. Usefulness of lamotrigine plasma concentration monitoring
51. Guidelines for therapeutic monitoring on antiepileptic drugs
52. Serum concentration of antiepileptic drugs: Guidelines for therapeutic monitoring and appropriate interpretation